Tg Therapeutics Inc (TGTX)

12:08 PM

TG Therapeutics Confronts Rising AI Regulatory and IP Risks That Could Pressure Costs, Strategy, and Growth - The Globe and Mail

12:08 PM

Mar 02, 2026

Precision BioSciences (DTIL) Hits Milestone, Secures $7.5M from TG Therapeutics - GuruFocus

Mar 02, 2026

Mar 02, 2026

TG Therapeutics, Inc. (TGTX) Growth Potential: Navigating A 47.65% Upside In Biotech - DirectorsTalk Interviews

Mar 02, 2026

Mar 02, 2026

Precision BioSciences Receives $7.5M in Proceeds from TG Therapeutics for Azer-cel Clinical Milestone in Multiple Sclerosis - Yahoo Finance

Mar 02, 2026

Mar 01, 2026

TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 01, 2026

Mar 01, 2026

TG Therapeutics (TGTX) Reports Financial Results for Q4 and Full Year 2025 - Finviz

Mar 01, 2026

Feb 28, 2026

TG Therapeutics (TGTX) Earnings Spark Debate As 72.6% Net Margin Defies Forecast Narratives - Sahm

Feb 28, 2026

Feb 28, 2026

TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line - The Globe and Mail

Feb 28, 2026

Feb 28, 2026

Decoding TG Therapeutics Inc (TGTX): A Strategic SWOT Insight - GuruFocus

Feb 28, 2026

Feb 28, 2026

TGTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 28, 2026

Feb 27, 2026

TG Therapeutics Five Year BRIUMVI Data And What It Means For Valuation - Yahoo Finance

Feb 27, 2026

Feb 27, 2026

TG Therapeutics (NASDAQ:TGTX) Announces Quarterly Earnings Results, Misses Expectations By $0.21 EPS - MarketBeat

Feb 27, 2026

Feb 27, 2026

TG THERAPEUTICS, INC. SEC 10-K Report - TradingView

Feb 27, 2026

Feb 27, 2026

TG Therapeutics: "Strong Buy" On BRIUMVI's Massive Growth And Possible Expansion (TGTX) - Seeking Alpha

Feb 27, 2026

Feb 27, 2026

(TGTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Feb 27, 2026

Feb 27, 2026

TG Therapeutics Experiences Evaluation Revision Amidst Evolving Market Dynamics - Markets Mojo

Feb 27, 2026

Feb 27, 2026

TG Therapeutics Q4 Earnings Call Highlights - Yahoo Finance

Feb 27, 2026

Feb 27, 2026

Q1 EPS Estimates for TG Therapeutics Raised by HC Wainwright - MarketBeat

Feb 27, 2026

Feb 27, 2026

Analysts’ Top Healthcare Picks: United Therapeutics (UTHR), TG Therapeutics (TGTX) - The Globe and Mail

Feb 27, 2026

Feb 26, 2026

TG Therapeutics: Q4 Earnings Snapshot - theheraldreview.com

Feb 26, 2026

Feb 26, 2026

TG Therapeutics (TGTX) Q4 2025 Earnings Transcript - The Globe and Mail

Feb 26, 2026

Feb 26, 2026

TG Therapeutics (TGTX) Misses Q4 Earnings Estimates - Yahoo! Finance Canada

Feb 26, 2026

Feb 26, 2026

Earnings call transcript: TG Therapeutics Q4 2025 earnings miss EPS expectations - Investing.com

Feb 26, 2026

Feb 26, 2026

TG Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2026

Feb 26, 2026

TG Therapeutics: Fourth Quarter Financial Highlights - Bitget

Feb 26, 2026

Feb 26, 2026

TG THERAPEUTICS INC (NASDAQ:TGTX) Q4 2025 Earnings Miss Estimates Despite Strong BRIUMVI Outlook - ChartMill

Feb 26, 2026

Feb 26, 2026

TG Therapeutics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

TG Therapeutics (TGTX) Reports Q4 Earnings Miss - GuruFocus

Feb 26, 2026

Feb 26, 2026

TG Therapeutics Q4 Earnings Fall, Revenue Rises; Issues 2026 Revenue Guidance; Shares Down Pre-bell - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Earnings Flash (TGTX) TG Therapeutics Posts Q4 EPS $0.14, vs. FactSet Est of $0.35 - marketscreener.com

Feb 26, 2026

Feb 26, 2026

TGTX Projects Strong Financial Performance Through 2026 - GuruFocus

Feb 26, 2026

Feb 26, 2026

TGTX Financial Health and Future Funding Outlook - GuruFocus

Feb 26, 2026

Feb 26, 2026

TG THERAPEUTICS ($TGTX) Releases Q4 2025 Earnings - Quiver Quantitative

Feb 26, 2026

Feb 26, 2026

TG Therapeutics Q4 revenue rises on BRIUMVI sales, but profit dips - TradingView

Feb 26, 2026

Feb 26, 2026

TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView

Feb 26, 2026

Feb 26, 2026

TG Therapeutics Q4 Earnings Assessment - Benzinga

Feb 26, 2026

Feb 26, 2026

TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance - GlobeNewswire

Feb 26, 2026

Feb 26, 2026

TG Therapeutics, Inc. $TGTX Stock Holdings Increased by Citigroup Inc. - MarketBeat

Feb 26, 2026

Feb 26, 2026

Five-Year BRIUMVI Data Shapes TG Therapeutics Multiple Sclerosis Investment Case - Sahm

Feb 26, 2026

Feb 25, 2026

A Look at TG Therapeutics's Upcoming Earnings Report - Benzinga

Feb 25, 2026

Feb 25, 2026

TG Therapeutics faces earnings test as Briumvi growth accelerates - Investing.com India

Feb 25, 2026

Feb 25, 2026

TG Therapeutics (TGTX) Set to Announce Q4 Earnings with Positive Revisions - GuruFocus

Feb 25, 2026

Feb 25, 2026

Vanguard Group Inc. Lowers Stock Position in TG Therapeutics, Inc. $TGTX - MarketBeat

Feb 25, 2026

Feb 25, 2026

FOMO Trade: Is TG Therapeutics Inc a top pick in the sectorWeekly Stock Summary & Precise Entry and Exit Recommendations - baoquankhu1.vn

Feb 25, 2026

Feb 24, 2026

Goldman Sachs raises TG Therapeutics, Inc. (TGTX) target to $39 on 2026 guidance - MSN

Feb 24, 2026

Feb 23, 2026

Aug Rallies: Is TG Therapeutics Inc undervalued by DCF analysisWeekly Investment Report & Expert Curated Trade Setup Alerts - baoquankhu1.vn

Feb 23, 2026

Feb 23, 2026

TG Therapeutics, Inc. (TGTX) Stock Analysis: A 50% Upside Potential In Biotech - DirectorsTalk Interviews

Feb 23, 2026

Feb 23, 2026

TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 Release - Finviz

Feb 23, 2026

Feb 23, 2026

TG Therapeutics to Host Conference Call Discussing Q4 and Full Year 2025 Financial Results and 2026 Outlook - Quiver Quantitative

Feb 23, 2026

Feb 23, 2026

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update - marketscreener.com

Feb 23, 2026

Feb 23, 2026

TG Therapeutics (TGTX) to Release Earnings on Monday - MarketBeat

Feb 23, 2026

Feb 23, 2026

TG Therapeutics sets Feb. 26 call on 2025 results, 2026 outlook - Stock Titan

Feb 23, 2026

Feb 22, 2026

Hussman Strategic Advisors Sells 126,000 TG Therapeutics Shares - AOL.com

Feb 22, 2026

Feb 21, 2026

What are TG Therapeutics Inc.’s recent SEC filings showing2025 EndofYear Setup & Safe Capital Preservation Plans - mfd.ru

Feb 21, 2026

Feb 20, 2026

What is TG Therapeutics Inc.’s valuation compared to sectorDay Trade & Smart Swing Trading Alerts - mfd.ru

Feb 20, 2026

Feb 20, 2026

Persistent Asset Partners Ltd Sells 71,539 Shares of TG Therapeutics, Inc. $TGTX - MarketBeat

Feb 20, 2026

Feb 20, 2026

Will TG Therapeutics Inc. benefit from AI trendsForecast Cut & AI Enhanced Trading Signals - mfd.ru

Feb 20, 2026

Feb 17, 2026

TG Therapeutics, Inc. Announces the Publication of Long Term/Five-Year Data from the Ongoing Open-Label Extension of the Phase 3 Ultimate I and Ii Studies - marketscreener.com

Feb 17, 2026

Feb 17, 2026

5-year MS study: BRIUMVI patients average one relapse every 50 years - Stock Titan

Feb 17, 2026

Feb 16, 2026

Liquidity Mapping Around (TGTX) Price Events - Stock Traders Daily

Feb 16, 2026

Feb 16, 2026

Portfolio Shifts: Should you avoid TG Therapeutics Inc stock right now2025 Investor Takeaways & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Feb 16, 2026

Feb 16, 2026

TG Therapeutics, Inc. (TGTX) Stock Analysis: A 55.89% Potential Upside in the Biotech Space - DirectorsTalk Interviews

Feb 16, 2026